Logo image of CNAT

Conatus Pharmaceutic (CNAT) Stock Income Statement

NASDAQ:CNAT - Nasdaq -

0.556  +0 (+0.18%)

After market: 0.54 -0.02 (-2.88%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

No data available